PUBLICATIONS

 Overview

In our lab, we strongly value collaboration and teamwork in all of our publications. This is what allows us to be able to publish successfully.

As of 2020, our all time stats include 2049 citations with an h-index of 26 and a i10 index of 47.

 

Selected Publications

For a complete list, please visit the National Library of Medicine.

  • Shireman, Jack M., et al. "De-novo purine biosynthesis is a major driver of chemoresistance in glioblastoma." bioRxiv (2020).

  • Baisiwala, Shivani, et al. "Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry." Stem cells international 2019 (2019).

  • Cordero, Alex, et al. "FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis." Oncogene 38.37 (2019): 6445-6460.

  • Miska J, Lee-Chang C, Rashidi A, et al. HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma. Cell Rep. 2019;27(1):226‐237.e4. doi:10.1016/j.celrep.2019.03.029

  • Chang AL, Miska J, Wainwright DA, et al. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Res. 2016;76(19):5671‐5682. doi:10.1158/0008-5472.CAN-16-0144

  • Fares J, Kanojia D, Rashidi A, Ahmed AU, Balyasnikova IV, Lesniak MS. Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations. Clin Breast Cancer. 2019;19(6):383‐391. doi:10.1016/j.clbc.2019.05.018

  • Caragher SP, Shireman JM, Huang M, et al. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma. J Neurosci. 2019;39(11):1982‐1993. doi:10.1523/JNEUROSCI.1589-18.2018

  • Kim JW, Kane JR, Panek WK, et al. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 2018;15(4):1127‐1138. doi:10.1007/s13311-018-0650-3

  • Caragher SP, Hall RR, Ahsan R, Ahmed AU. Monoamines in glioblastoma: complex biology with therapeutic potential. Neuro Oncol. 2018;20(8):1014‐1025. doi:10.1093/neuonc/nox210

  • Manna PR, Ahmed AU, Yang S, et al. Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective. Cancers (Basel). 2019;11(5):623. Published 2019 May 4. doi:10.3390/cancers11050623

  • Bentley RT, Ahmed AU, Yanke AB, Cohen-Gadol AA, Dey M. Dogs are man's best friend: in sickness and in health. Neuro Oncol. 2017;19(3):312‐322. doi:10.1093/neuonc/now109

  • Young JS, Kim JW, Ahmed AU, Lesniak MS. Therapeutic cell carriers: a potential road to cure glioma. Expert Rev Neurother. 2014;14(6):651‐660. doi:10.1586/14737175.2014.917964

  • Kim J, Hall RR, Lesniak MS, Ahmed AU. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions. Viruses. 2015;7(12):6200‐6217. Published 2015 Nov 27. doi:10.3390/v7122921

  • Lee, Gina, et al. "Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model." Molecular cancer therapeutics 15.12 (2016): 3064-3076.

  • Lee, Gina, Robert R. Hall III, and Atique U. Ahmed. "Cancer stem cells: cellular plasticity, niche, and its clinical relevance." Journal of stem cell research & therapy 6.10 (2016).

  • Kanojia, Deepak, et al. "βIII-Tubulin regulates breast cancer metastases to the brain." Molecular cancer therapeutics 14.5 (2015): 1152-1161.

  • Alexiades, Nikita G., et al. "MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells." Stem cell research 15.3 (2015): 598-607.

  • Auffinger, Brenda, et al. "Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy." Cell death and differentiation 21.7 (2014): 1119.

  • Deheeger, Marc, Maciej S. Lesniak, and Atique U. Ahmed. "Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance." Cancer cell & microenvironment 1.5 (2014).

  • Ahmed, Atique U., et al. "Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma." Molecular Therapy 19.9 (2011): 1714-1726.

  • Ahmed, Atique, et al. "A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization." Nature biotechnology 21.7 (2003): 771-777.